February is American Heart Month.
Each year, approximately one million babies are born with congenital heart disease (CHD) worldwide, which is one percent of all newborns. One out of three born with CHD are discharged from the hospital without detection. Congenital heart diseases, along with 56 other conditions, are recommended as conditions for routine screenings (core plus secondary conditions) for all newborns in the United States. Thanks to the innovative technology developed by OZ Systems, newborn heart defects are being detected before babies leave the hospital when early intervention can take place, significantly improving health outcomes for infants. OZ Systems pulse oximetry technology measures the percentage of hemoglobin in the blood that is saturated with oxygen, a key indicator in heart health.
Screening for CHD differs from other newborn screenings because newborns with CHD typically appear normal at birth. A baby can appear perfectly fine, but develop life-threatening symptoms shortly after being discharged. Healthcare providers such as nurses or nursing assistants, who are responsible for conducting CHD screenings and accurately interpreting the results, often encounter the challenge of inefficient tools to report, track and store data. State and Federal policies have been made to ensure that all newborns are screened for CHD. More than 10 million babies have been screened and more than 3,000 babies’ lives have been saved. Other countries including Australia, the Philippines, China, Ethiopia, Nigeria, Morocco, Kuwait, and Qatar are exploring efforts to implement screening programs.
With the continual focus behind the screening protocol and measurement, the most important next steps involve creating smart and efficient reporting systems. OZ Systems has developed targeted products OZ STARTM, OZ BabyBundleTM, OZ NANITM, and others to provide efficient, effective tools for healthcare providers to measure, analyze and determine outcomes associated with screenings.
We invite you to join us as we raise awareness of these conditions by learning, sharing, supporting and speaking out about the importance of newborn CHD screenings.
Please contact OZ Systems (email@example.com) for more information about tools that fit your hospital or state program needs.
Learn about OZ Systems’ intelligent Newborn Screening programs OZ STARTM and OZ BabyBundleTM at http://www.ozsystems.com/hospitals-providers/oz-intelligent-newborn-screening.